Synthesis and Evaluation of Novel Thymidine Analogs as Antitumor and Antiviral Agents

Two series of thymidine analogs with a hydroxyalkylammonium(amine) moiety have been synthesized and evaluated for antitumor and antiviral activities. The hydroxyalkylammonium(amine) group was introduced at the 5‘ position of the 2‘-deoxyribose residue of thymidine or at a corresponding position in acyclic thymidine analogs. In order to increase the lipophilicity of these compounds and potentially enable them to cross the cell membrane, the free hydroxy group also was esterified with a long hydrocarbon chain. The hexadecanoyl analogs (compounds 1c, 1d, 7c, and 7d) showed moderate antitumor cytotoxicity against SV-28 and KB cell lines (IC50 ∼ 20 μM). Compound 1d showed moderate anti-HIV activity (EC50 = 6.8 μM), while compound 5 showed weak anti-HIV activity (EC50 = 55 μM). None of the compounds showed antiherpes simplex virus activity.